Ultomiris Market Report 2026
Download Free Sample Buy Now
Ultomiris Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Ultomiris Market Report 2026

Global Outlook – By Indication (Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), Neuromyelitis Optica Spectrum Disorder (NMOSD)), By Formulation (Intravenous Solution, Subcutaneous Formulation), By Distribution Channel (Hospital And Clinics, Retail And Specialty Pharmacies), By End User (Adult Patients, Pediatric Patients) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Ultomiris Market Overview

• The Ultomiris market growth in the historic period has been driven by improved diagnosis of rare autoimmune diseases, advancements in monoclonal antibody engineering

• Market expansion is supported by increasing investments in rare disease drug development, rising adoption of subcutaneous formulations

• Growth Driver: Impact Of Increasing Autoimmune Conditions On The Growth Of The Market

• Market Trend: Drug Approval For Ultomiris In Neuromyelitis Optica Spectrum Disorder (NMOSD)

• North America was the largest region in 2025.

What Is Covered Under Ultomiris Market?

Ultomiris is a prescription medication with the active ingredient ravulizumab-cwvz, a monoclonal antibody that inhibits a component of the immune system known as C5 in the complement cascade. It treats certain rare and severe autoimmune diseases by preventing the immune system from attacking healthy cells.

The main types of clinical indications in ultomiris are paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired disorder where red blood cells are destroyed prematurely, leading to hemolysis and blood clotting. It includes various formulations, such as intravenous solutions and subcutaneous formulations, and is distributed through hospitals and clinics and retail and specialty pharmacies. It caters to various end users, such as adult patients and pediatric patients.

Ultomiris Market Global Report 2026 Market Report bar graph

What Is The Ultomiris Market Size and Share 2026?

The growth in the historic period can be attributed to improved diagnosis of rare autoimmune diseases, advancements in monoclonal antibody engineering, expansion of biologics reimbursement frameworks, increased clinician awareness of complement disorders, availability of hospital infusion infrastructure.

What Is The Ultomiris Market Growth Forecast?

The growth in the forecast period can be attributed to increasing investments in rare disease drug development, rising adoption of subcutaneous formulations, expansion of home-based infusion care, growing focus on long-term disease management, increasing demand for reduced treatment burden therapies. Major trends in the forecast period include increasing adoption of long-acting complement inhibitors, rising preference for extended dosing intervals, growing use of targeted autoimmune therapies, expansion of rare disease treatment programs, enhanced focus on patient-centric infusion models.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Ultomiris Market Segmentation

1) By Indication: Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), Neuromyelitis Optica Spectrum Disorder (NMOSD)

2) By Formulation: Intravenous Solution, Subcutaneous Formulation

3) By Distribution Channel: Hospital And Clinics, Retail And Specialty Pharmacies

4) By End User: Adult Patients, Pediatric Patients

What Are The Drivers Of The Ultomiris Market?

The increasing prevalence of autoimmune conditions is expected to propel the growth of the ultomiris market going forward. Autoimmune conditions refer to disorders in which the immune system mistakenly attacks and damages the body’s healthy cells and tissues. The increasing prevalence of autoimmune conditions can be attributed to both environmental factors, such as exposure to pollutants and chemicals, and improved diagnosis, which has led to more people being identified and treated for these diseases. Ultomiris treats autoimmune conditions such as Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS) by inhibiting complement protein C5, reducing immune attacks on the body. For instance, in February 2024 according to the Arthritis Australia is a Australia-based non-profit organization In 2025, an estimated 212,136 males and 362,137 females are projected to have rheumatoid arthritis (RA), with the numbers expected to rise by 2040 to approximately 280,040 males and 479,828 females. Therefore, the increasing prevalence of autoimmune conditions is driving the growth of the ultomiris industry.

The rising healthcare expenditure is expected to propel the growth of the ultomiris market going forward. Healthcare expenditure refers to the financial resources spent on a country or region's medical services, infrastructure, insurance, and related activities. The rise in healthcare expenditure is due to the aging population and the increasing prevalence of chronic diseases, leading to higher ongoing medical management costs. Healthcare expenditure for ultomiris is used to cover the cost of the drug, its administration, patient monitoring, and continuing research and development to expand its therapeutic indications. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, healthcare expenditure in the USA rose by 5.6% in nominal terms from 2022 to 2023, marking a significant increase compared to the 0.9% growth observed in 2022. Therefore, rising healthcare expenditure is expected to propel the growth of the ultomiris industry.

Key Players In The Global Ultomiris Market

Major companies operating in the ultomiris market are AstraZeneca Plc.

Global Ultomiris Market Trends and Insights

The key trend in the ultomiris market is drug approval from regulatory authorities to expand its therapeutic indications and market reach. Drug approval is the process by which regulatory authorities evaluate and authorize a new drug for sale and use, ensuring its safety, efficacy, and quality based on clinical trial data. For instance, in March 2024, AstraZeneca, a UK-based pharmaceutical industry company, received the Food and Drug Administration (FDA) approval for ULTOMIRIS (ravulizumab-cwvz) for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) who are favorable for the anti-aquaporin-4 (AQP4) antibody. This approval is significant as ULTOMIRIS is the first long-acting C5 complement inhibitor for NMOSD, shown to reduce relapse risk by 98.6% in clinical trials. ULTOMIRIS helps prevent immune attacks on the central nervous system by inhibiting the complement system. However, it carries risks, including serious meningococcal infections and common side effects such as headache and urinary tract infections.

Need data on a specific region in this market?
Request Regional Data

Regional Insights

North America was the largest region in the ultomiris market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Ultomiris Market?

The ultomiris market consists of sales of ultomiris injections, alpha-1 proteinase inhibitors, subcutaneous injections, and monoclonal antibodies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ultomiris Market Report 2026?

The ultomiris market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ultomiris industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Ultomiris Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate No CAGR found from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Indication, Formulation, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled AstraZeneca Plc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Ultomiris Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Ultomiris Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Ultomiris Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Ultomiris Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Long-Acting Complement Inhibitors

4.2.2 Rising Preference For Extended Dosing Intervals

4.2.3 Growing Use Of Targeted Autoimmune Therapies

4.2.4 Expansion Of Rare Disease Treatment Programs

4.2.5 Enhanced Focus On Patient-Centric Infusion Models

5. Ultomiris Market Analysis Of End Use Industries

5.1 Adult Patients

5.2 Pediatric Patients

5.3 Neurology Clinics

5.4 Nephrology Centers

5.5 Hospitals

6. Ultomiris Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ultomiris Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Ultomiris PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Ultomiris Market Size, Comparisons And Growth Rate Analysis

7.3. Global Ultomiris Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Ultomiris Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ultomiris Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ultomiris Market Segmentation

9.1. Global Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), Neuromyelitis Optica Spectrum Disorder (NMOSD)

9.2. Global Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous Solution, Subcutaneous Formulation

9.3. Global Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital And Clinics, Retail And Specialty Pharmacies

9.4. Global Ultomiris Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult Patients, Pediatric Patients

10. Ultomiris Market Regional And Country Analysis

10.1. Global Ultomiris Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Ultomiris Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ultomiris Market

11.1. Asia-Pacific Ultomiris Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ultomiris Market

12.1. China Ultomiris Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ultomiris Market

13.1. India Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ultomiris Market

14.1. Japan Ultomiris Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ultomiris Market

15.1. Australia Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Ultomiris Market

16.1. South Korea Ultomiris Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Ultomiris Market

17.1. Western Europe Ultomiris Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Ultomiris Market

18.1. UK Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Ultomiris Market

19.1. Germany Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Ultomiris Market

20.1. France Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Ultomiris Market

21.1. Eastern Europe Ultomiris Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Ultomiris Market

22.1. North America Ultomiris Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Ultomiris Market

23.1. USA Ultomiris Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Ultomiris Market

24.1. Canada Ultomiris Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Ultomiris Market

25.1. South America Ultomiris Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Ultomiris Market

26.1. Middle East Ultomiris Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Ultomiris Market

27.1. Africa Ultomiris Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Ultomiris Market, Segmentation By Indication, Segmentation By Formulation, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Ultomiris Market Regulatory and Investment Landscape

29. Ultomiris Market Competitive Landscape And Company Profiles

29.1. Ultomiris Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Ultomiris Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Ultomiris Market Company Profiles

29.3.1. AstraZeneca Plc. Overview, Products and Services, Strategy and Financial Analysis

30. Global Ultomiris Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Ultomiris Market

32. Ultomiris Market High Potential Countries, Segments and Strategies

32.1 Ultomiris Market In 2030 - Countries Offering Most New Opportunities

32.2 Ultomiris Market In 2030 - Segments Offering Most New Opportunities

32.3 Ultomiris Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Ultomiris Market, Overview Of Key Products - Product Examples
  • Table 2: Global Ultomiris Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Ultomiris Market, Supply Chain Analysis
  • Table 4: Global Ultomiris Market, Major Raw Material Providers
  • Table 5: Global Ultomiris Market, Major Resource Providers
  • Table 6: Global Ultomiris Market, Major Manufacturers (Suppliers)
  • Table 7: Global Ultomiris Market, Major Distributors And Channel Partners
  • Table 8: Global Ultomiris Market, Key Technologies & Future Trends
  • Table 9: Global Ultomiris Market, Major Trends
  • Table 10: Global Ultomiris Market, Major End Users
  • Table 11: Global Ultomiris Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Ultomiris Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Ultomiris Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Ultomiris Market - TAM, US$ Billion, 2025
  • Table 15: Global Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Ultomiris Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Ultomiris Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Ultomiris Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: South Korea, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Western Europe, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Western Europe, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: UK, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: UK, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Germany, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Germany, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: France, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: France, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Eastern Europe, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Eastern Europe, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: North America, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: North America, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: USA, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: USA, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Canada, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Canada, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: South America, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: South America, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Middle East, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Middle East, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Africa, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Africa, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Global Ultomiris Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 73: Global Ultomiris Market - Company Scoring Matrix
  • Table 74: AstraZeneca Plc. Financial Performance
  • Table 75: Global Ultomiris Market, Competitive Benchmarking (In USD Billions)
  • Table 76: Global Ultomiris Market, Competitive Dashboard
  • Table 77: Global Ultomiris Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 78: Global, Ultomiris Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 79: Global, Ultomiris Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Table 80: Global, Ultomiris Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Ultomiris Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Ultomiris Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Ultomiris Market, Supply Chain Analysis
  • Figure 4: Global Ultomiris Market, Major Raw Material Providers
  • Figure 5: Global Ultomiris Market, Major Resource Providers
  • Figure 6: Global Ultomiris Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Ultomiris Market, Major Distributors And Channel Partners
  • Figure 8: Global Ultomiris Market, Key Technologies & Future Trends
  • Figure 9: Global Ultomiris Market, Major Trends
  • Figure 10: Global Ultomiris Market, Major End Users
  • Figure 11: Global Ultomiris Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Ultomiris Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Ultomiris Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Ultomiris Market - TAM, US$ Billion, 2025
  • Figure 15: Global Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Ultomiris Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Ultomiris Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Ultomiris Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: South Korea, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Western Europe, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Western Europe, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: UK, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: UK, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Germany, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Germany, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: France, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: France, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Eastern Europe, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Eastern Europe, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: North America, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: North America, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: USA, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: USA, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Canada, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Canada, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: South America, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: South America, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Middle East, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Middle East, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Africa, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Africa, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Global Ultomiris Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 73: Global Ultomiris Market - Company Scoring Matrix
  • Figure 74: AstraZeneca Plc. Financial Performance
  • Figure 75: Global Ultomiris Market, Competitive Benchmarking (In USD Billions)
  • Figure 76: Global Ultomiris Market, Competitive Dashboard
  • Figure 77: Global Ultomiris Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 78: Global, Ultomiris Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 79: Global, Ultomiris Market Size Gain ($ Billion), Segmentation By Formulation, 2025 – 2030
  • Figure 80: Global, Ultomiris Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Drug Delivery Devices Market 2021 - By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug D...

Autoimmune Disease Diagnosis Market 2022 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic T...

Autoimmune Treatment Market Report 2026 - Global Outlook – By Service Type (Consultation And Diagnosis, Therapy And Monitoring, Drug development), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s...

Immune Health Supplements Market Report 2026 - Global Outlook – By Ingredients Type (Vitamins, Minerals, Herbal Botanical Extracts, Probiotics, Amino Acids, Omega 3 - Fatty Acids), By Form (Soft Gels Or Capsules, Tablets...

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Market Report 2026 - Global Outlook – By Product (Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, Durvalumab), By Distribution Channel (Hospital pharmacies, Retail...

Insulin Drugs Market Report 2026 - Global Outlook – By Product Type (Basal Or Long-Acting Insulins, Bolus Or Fast-Acting Insulins, Pre-Mixed, Intermediate And Short Acting Insulins), By Source Type (Insulin Analogs, And ...

Autoimmune Disease Diagnosis Market Report 2026 - Global Outlook – By Product (Consumables And Assay Kits, Instruments), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests), By E...

G-CSF (Granulocyte Colony Stimulating Factors) Market 2021 - By Type (Pegfilgrastim, Filgrastim, Lenograstim), By Application (Oncology, Blood Disorders, Chronic and Autoimmune Disorders), And By Region, Opportunities An...

Frequently Asked Questions

The Ultomiris market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Ultomiris market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Ultomiris market Include, AstraZeneca Plc. .

Major trend in this market includes: Drug Approval For Ultomiris In Neuromyelitis Optica Spectrum Disorder (NMOSD). For further insights on this market. request a sample here

North America was the largest region in the ultomiris market in 2025. The regions covered in the ultomiris market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us